Study S002099

Wegovy® (Semaglutide 2.4 mg) Pregnancy Registry Study: A Prospective Cohort Study to Investigate Safety Outcomes of Exposure to Wegovy During Pregnancy

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05872022
Study type: OBSERVATIONAL
Status: ENROLLING_BY_INVITATION
Enrollment: 728
Start: 2023-07-05
Primary completion: 2032-10-31
Lead sponsor: Novo Nordisk A/S
Conditions: Pregnancy; Obesity; Overweight
Interventions: OTHER:No Intervention
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1273-4336

Registered primary outcomes

Number of Infants with Major Congenital Malformation (MCM) [From date of conception (DOC) to pregnancy outcome for foetal losses or 12 months of infant age for live births]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.